Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aerie Pharmaceuticals Inc (AERI) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aerie Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1337553.
Total stock buying since 2014: $27,194,114.
Total stock sales since 2014: $220,789,847.
Total stock option exercises since 2014: $2,415,282.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 0 | $0 | 0 | $0 | 60,651 | $11,887 |
| 2020 | 0 | $0 | 1,035,000 | $17,536,531 | 28,000 | $88,200 |
| 2019 | 961,745 | $22,399,952 | 22,000 | $899,107 | 117,000 | $47,385 |
| 2018 | 4,000 | $183,189 | 570,827 | $34,747,419 | 396,251 | $1,213,534 |
| 2017 | 3,000 | $123,300 | 61,591 | $3,058,491 | 58,167 | $1,054,276 |
| 2016 | 250,000 | $4,375,000 | 50,000 | $2,017,000 | 0 | $0 |
| 2015 | 4,646 | $84,734 | 623,620 | $20,471,776 | 0 | $0 |
| 2014 | 1,854 | $27,939 | 5,870,404 | $142,059,523 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-02 | 0 | $0 | 0 | $0 | 60,651 | $11,887 |
| 2020-11 | 0 | $0 | 30,000 | $390,181 | 0 | $0 |
| 2020-05 | 0 | $0 | 5,000 | $76,350 | 28,000 | $88,200 |
| 2020-02 | 0 | $0 | 1,000,000 | $17,070,000 | 0 | $0 |
| 2019-12 | 0 | $0 | 0 | $0 | 117,000 | $47,385 |
| 2019-09 | 197,190 | $3,801,387 | 0 | $0 | 0 | $0 |
| 2019-08 | 764,555 | $18,598,565 | 0 | $0 | 0 | $0 |
| 2019-02 | 0 | $0 | 11,000 | $511,797 | 0 | $0 |
| 2019-01 | 0 | $0 | 11,000 | $387,310 | 0 | $0 |
| 2018-12 | 0 | $0 | 11,000 | $441,837 | 0 | $0 |
| 2018-11 | 2,000 | $83,494 | 11,000 | $589,699 | 0 | $0 |
| 2018-10 | 0 | $0 | 11,000 | $669,702 | 0 | $0 |
| 2018-09 | 0 | $0 | 112,119 | $6,779,709 | 0 | $0 |
| 2018-08 | 0 | $0 | 201,000 | $12,272,623 | 190,000 | $598,500 |
| 2018-07 | 0 | $0 | 11,000 | $732,809 | 0 | $0 |
| 2018-06 | 0 | $0 | 211,000 | $13,125,234 | 200,000 | $598,750 |
| 2018-05 | 2,000 | $99,695 | 2,708 | $135,806 | 3,000 | $15,000 |
| 2018-02 | 0 | $0 | 0 | $0 | 3,251 | $1,284 |
| 2017-05 | 1,000 | $39,900 | 20,000 | $1,119,000 | 0 | $0 |
| 2017-04 | 2,000 | $83,400 | 0 | $0 | 0 | $0 |
| 2017-02 | 0 | $0 | 41,591 | $1,939,491 | 58,167 | $1,054,276 |
| 2016-10 | 0 | $0 | 50,000 | $2,017,000 | 0 | $0 |
| 2016-07 | 250,000 | $4,375,000 | 0 | $0 | 0 | $0 |
| 2015-08 | 3,646 | $59,664 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-15 | Kopczynski Casey C. (Chief Scientific Officer) | Option Ex | 60,651 | .20 | 11,887 |
| 2020-11-11 | Kopczynski Casey C. (Chief Scientific Officer) | Sale | 22,695 | 13.01 | 295,216 |
| 2020-11-10 | Kopczynski Casey C. (Chief Scientific Officer) | Sale | 7,305 | 13.00 | 94,965 |
| 2020-05-18 | Goldberg Murray A (Director) | Option Ex | 28,000 | 3.15 | 88,200 |
| 2020-05-08 | Cagle Gerald D. (Director) | Sale | 5,000 | 15.27 | 76,350 |
| 2020-02-27 | Tananbaum James B. (10% Owner) | Sale | 1,000,000 | 17.07 | 17,070,000 |
| 2019-12-03 | Kopczynski Casey C. (Chief Scientific Officer) | Option Ex | 117,000 | .41 | 47,385 |
| 2019-09-09 | Rubino Richard J (Chief Financial Officer) | Buy | 5,040 | 19.93 | 100,447 |
| 2019-09-09 | Anido Vicente Jr (Chief Executive Officer) | Buy | 26,250 | 19.44 | 510,300 |
| 2019-09-05 | Tananbaum James B. (10% Owner) | Buy | 15,700 | 18.42 | 289,194 |
| 2019-09-04 | Tananbaum James B. (10% Owner) | Buy | 100,200 | 18.48 | 1,851,696 |
| 2019-09-03 | Tananbaum James B. (10% Owner) | Buy | 50,000 | 21.00 | 1,049,750 |
| 2019-08-30 | Tananbaum James B. (10% Owner) | Buy | 25,000 | 21.36 | 534,000 |
| 2019-08-23 | Tananbaum James B. (10% Owner) | Buy | 38,300 | 23.42 | 896,986 |
| 2019-08-22 | Tananbaum James B. (10% Owner) | Buy | 6,700 | 23.68 | 158,656 |
| 2019-08-21 | Tananbaum James B. (10% Owner) | Buy | 1,153 | 23.25 | 26,807 |
| 2019-08-20 | Tananbaum James B. (10% Owner) | Buy | 50,000 | 23.21 | 1,160,500 |
| 2019-08-19 | Tananbaum James B. (10% Owner) | Buy | 3,847 | 23.34 | 89,788 |
| 2019-08-16 | Tananbaum James B. (10% Owner) | Buy | 100,000 | 24.23 | 2,423,000 |
| 2019-08-14 | Tananbaum James B. (10% Owner) | Buy | 100,000 | 23.73 | 2,373,000 |
| 2019-08-13 | Tananbaum James B. (10% Owner) | Buy | 250,000 | 25.22 | 6,305,000 |
| 2019-08-12 | Tananbaum James B. (10% Owner) | Buy | 189,555 | 24.43 | 4,630,828 |
| 2019-02-01 | Kopczynski Casey C. (Chief Scientific Officer) | Sale | 11,000 | 46.53 | 511,797 |
| 2019-01-02 | Kopczynski Casey C. (Chief Scientific Officer) | Sale | 11,000 | 35.21 | 387,310 |
| 2018-12-03 | Kopczynski Casey C. (Chief Scientific Officer) | Sale | 11,000 | 40.17 | 441,837 |
| 2018-11-16 | Cagle Gerald D. (Director) | Buy | 2,000 | 41.75 | 83,494 |
| 2018-11-01 | Kopczynski Casey C. (Chief Scientific Officer) | Sale | 11,000 | 53.61 | 589,699 |
| 2018-10-01 | Kopczynski Casey C. (Chief Scientific Officer) | Sale | 11,000 | 60.88 | 669,702 |
| 2018-09-27 | Rubino Richard J (Chief Financial Officer) | Sale | 16,605 | 60.69 | 1,007,707 |
| 2018-09-26 | Rubino Richard J (Chief Financial Officer) | Sale | 50,000 | 60.59 | 3,029,750 |
| 2018-09-14 | Rubino Richard J (Chief Financial Officer) | Sale | 2 | 60.00 | 120 |
| 2018-09-13 | Rubino Richard J (Chief Financial Officer) | Sale | 34,512 | 60.17 | 2,076,621 |
| 2018-09-04 | Kopczynski Casey C. (Chief Scientific Officer) | Sale | 11,000 | 60.50 | 665,511 |
| 2018-08-27 | Mitro Thomas A (President and COO) | Sale | 190,000 | 60.64 | 11,520,840 |
| 2018-08-27 | Mitro Thomas A (President and COO) | Option Ex | 190,000 | 3.15 | 598,500 |
| 2018-08-01 | Kopczynski Casey C. (Chief Scientific Officer) | Sale | 11,000 | 68.34 | 751,783 |
| 2018-07-02 | Kopczynski Casey C. (Chief Scientific Officer) | Sale | 11,000 | 66.62 | 732,809 |
| 2018-06-11 | Anido Vicente Jr (Chief Executive Officer) | Sale | 50,000 | 62.41 | 3,120,600 |
| 2018-06-11 | Anido Vicente Jr (Chief Executive Officer) | Option Ex | 50,000 | 3.15 | 157,500 |
| 2018-06-08 | Anido Vicente Jr (Chief Executive Officer) | Sale | 50,000 | 63.94 | 3,196,750 |
| 2018-06-08 | Anido Vicente Jr (Chief Executive Officer) | Option Ex | 50,000 | 3.02 | 151,250 |
| 2018-06-07 | Anido Vicente Jr (Chief Executive Officer) | Sale | 50,000 | 62.43 | 3,121,500 |
| 2018-06-07 | Anido Vicente Jr (Chief Executive Officer) | Option Ex | 50,000 | 2.90 | 145,000 |
| 2018-06-06 | Kopczynski Casey C. (Chief Scientific Officer) | Sale | 11,000 | 58.89 | 647,834 |
| 2018-06-06 | Anido Vicente Jr (Chief Executive Officer) | Sale | 50,000 | 60.77 | 3,038,550 |
| 2018-06-06 | Anido Vicente Jr (Chief Executive Officer) | Option Ex | 50,000 | 2.90 | 145,000 |
| 2018-05-29 | Kopczynski Casey C. (Chief Scientific Officer) | Sale | 2,708 | 50.15 | 135,806 |
| 2018-05-25 | Cagle Gerald D. (Director) | Buy | 1,000 | 49.45 | 49,450 |
| 2018-05-24 | Kopczynski Casey C. (Chief Scientific Officer) | Option Ex | 3,000 | 5.00 | 15,000 |
| 2018-05-21 | Cagle Gerald D. (Director) | Buy | 1,000 | 50.24 | 50,245 |
| 2018-02-09 | Kopczynski Casey C. (Chief Scientific Officer) | Option Ex | 3,251 | .40 | 1,284 |
| 2017-05-26 | Tananbaum James B. (10% Owner) | Sale | 20,000 | 55.95 | 1,119,000 |
| 2017-05-09 | Cagle Gerald D. (Director) | Buy | 1,000 | 39.90 | 39,900 |
| 2017-04-19 | Cagle Gerald D. (Director) | Buy | 2,000 | 41.70 | 83,400 |
| 2017-02-15 | Duyk Geoffrey M (Director) | Sale | 20,796 | 46.81 | 973,439 |
| 2017-02-14 | Duyk Geoffrey M (Director) | Sale | 20,795 | 46.46 | 966,052 |
| 2017-02-14 | Duyk Geoffrey M (Director) | Option Ex | 58,167 | 18.12 | 1,054,276 |
| 2016-10-06 | Tananbaum James B. (10% Owner) | Sale | 50,000 | 40.34 | 2,017,000 |
| 2016-07-22 | Tananbaum James B. (10% Owner) | Buy | 250,000 | 17.50 | 4,375,000 |
| 2015-08-28 | Cagle Gerald D. (Director) | Buy | 2,000 | 16.60 | 33,200 |
| 2015-08-12 | Cagle Gerald D. (Director) | Buy | 500 | 15.46 | 7,729 |
| 2015-08-10 | Cagle Gerald D. (Director) | Buy | 1,146 | 16.35 | 18,735 |
| 2015-04-15 | Mehra Anand (Director) | Sale | 294,298 | 33.45 | 9,843,973 |
| 2015-04-14 | Mehra Anand (Director) | Sale | 130,702 | 34.08 | 4,453,932 |
| 2015-02-05 | Cagle Gerald D. (Director) | Buy | 500 | 24.54 | 12,270 |
| 2015-02-04 | Cagle Gerald D. (Director) | Buy | 500 | 25.60 | 12,800 |
| 2015-01-08 | Wheeler Kurt (10% Owner) | Sale | 175,000 | 31.11 | 5,444,250 |
| 2015-01-05 | Wheeler Kurt (10% Owner) | Sale | 23,620 | 30.89 | 729,621 |
| 2014-12-29 | Wheeler Kurt (10% Owner) | Sale | 6,214 | 30.03 | 186,606 |
| 2014-12-26 | Wheeler Kurt (10% Owner) | Sale | 74,510 | 30.05 | 2,239,025 |
| 2014-12-23 | Wheeler Kurt (10% Owner) | Sale | 263 | 30.00 | 7,890 |
| 2014-12-22 | Wheeler Kurt (10% Owner) | Sale | 49,441 | 30.36 | 1,501,028 |
| 2014-11-25 | Mehra Anand | Sale | 800,000 | 26.00 | 20,800,000 |
| 2014-11-25 | Coulter James G | Sale | 1,300,000 | 25.97 | 33,761,000 |
| 2014-07-10 | Mehra Anand (10% Owner) | Sale | 8,022 | 25.81 | 207,031 |
| 2014-07-10 | Powell Michael (10% Owner) | Sale | 8,022 | 25.81 | 207,031 |
| 2014-07-10 | Coulter James G | Sale | 500,000 | 25.28 | 12,640,000 |
| 2014-07-09 | Mehra Anand (10% Owner) | Sale | 1,000,000 | 24.00 | 24,001,000 |
| 2014-07-09 | Powell Michael (10% Owner) | Sale | 1,000,000 | 24.00 | 24,001,000 |
| 2014-07-09 | Coulter James G | Sale | 500,000 | 25.05 | 12,525,000 |
| 2014-05-22 | Sofinnova Management Vii, L.l.c. (10% Owner) | Sale | 323,932 | 16.00 | 5,182,912 |
| 2014-05-22 | Nohra Guy P (10% Owner) | Sale | 300,000 | 16.00 | 4,800,000 |
| 2014-05-16 | Cagle Gerald D. (Director) | Buy | 1,854 | 15.07 | 27,939 |
Insider trading activities including stock purchases, stock sales, and option exercises of AERI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aerie Pharmaceuticals Inc (symbol AERI, CIK number 1337553) see the Securities and Exchange Commission (SEC) website.